tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Corbus Pharmaceuticals appoints Jacques as Chair of Board of Directors
PremiumThe FlyCorbus Pharmaceuticals appoints Jacques as Chair of Board of Directors
2M ago
Corbus Pharmaceuticals price target lowered to $28 from $40 at B. Riley
Premium
The Fly
Corbus Pharmaceuticals price target lowered to $28 from $40 at B. Riley
3M ago
Corbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
Premium
The Fly
Corbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
3M ago
Corbus Pharmaceuticals reports Q1 EPS ($1.39), consensus ($1.07)
PremiumThe FlyCorbus Pharmaceuticals reports Q1 EPS ($1.39), consensus ($1.07)
3M ago
Corbus Pharmaceuticals management to meet with Piper Sandler
Premium
The Fly
Corbus Pharmaceuticals management to meet with Piper Sandler
3M ago
Corbus announces first patient dosed in Phase 1 CRB-913 study
Premium
The Fly
Corbus announces first patient dosed in Phase 1 CRB-913 study
4M ago
Corbus Pharmaceuticals price target lowered to $53 from $70 at Jefferies
PremiumThe FlyCorbus Pharmaceuticals price target lowered to $53 from $70 at Jefferies
5M ago
Corbus Pharmaceuticals Reports Q4 2024 Financial Results
Premium
Company Announcements
Corbus Pharmaceuticals Reports Q4 2024 Financial Results
5M ago
Corbus Pharmaceuticals reports Q4 EPS (78c), consensus ($1.26)
Premium
The Fly
Corbus Pharmaceuticals reports Q4 EPS (78c), consensus ($1.26)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100